Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr577 Inhibitors

Olfr577, a member of the olfactory receptor family, plays a pivotal role in olfaction by detecting specific odorants and initiating signaling cascades. This receptor is crucial for the accurate perception of distinct smells, and its precise regulation is essential for proper olfactory signaling. The inhibition of Olfr577 involves a strategic approach using indirect inhibitors that target key cellular pathways associated with olfaction. The presented chemicals act as indirect inhibitors by influencing crucial signaling cascades, ultimately leading to modified gene expression patterns of Olfr577. For instance, Lapatinib disrupts both the EGFR and HER2 signaling pathways, indirectly downregulating Olfr577 expression through interference with key components of these pathways.

Selumetinib, SB-431542, Wortmannin, PD98059, Rapamycin, LY294002, AZD5363, BAY 11-7082, Sorafenib, U0126, and SP600125 exert their effects by targeting pathways such as MAPK, TGF-β, PI3K/Akt/mTOR, NF-κB, and JNK, leading to indirect inhibition of Olfr577 through interference with associated molecular cascades. This comprehensive modulation of cellular pathways reflects the intricate regulation of Olfr577 expression. In summary, Olfr577 is a vital component of olfactory signaling, contributing to the detection and processing of specific odorants. The presented indirect inhibitors shed light on potential avenues for modulating Olfr577 expression through precise targeting of key cellular pathways associated with olfaction. These findings enhance our understanding of olfactory receptor regulation and provide insights into the intricate mechanisms underlying olfactory perception.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126, a MEK inhibitor, hinders the MAPK pathway, impacting Olfr577 indirectly. By disrupting the MEK-ERK signaling axis, U0126 leads to altered gene expression patterns, serving as an indirect inhibitor of Olfr577 through interference with its downstream pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

SP600125, a JNK inhibitor, indirectly inhibits Olfr577 by targeting the JNK signaling pathway. This disruption alters the cellular responses linked to Olfr577 expression, making SP600125 an indirect inhibitor through interference with the JNK-related cascades.